Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion

Autor: Sonbul, Sultan N, Aleskandarany, Mohammed A, Kurozumi, Sasagu, Joseph, Chitra, Toss, Michael S, Diez-Rodriguez, Maria, Nolan, Christopher C, Mukherjee, Abhik, Martin, Stewart, Caldas, Carlos, Ellis, Ian O, Green, Andrew R, Rakha, Emad A

Publikováno v: In Modern Pathology January 2018 31(11):1675-1682

Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer.

Autor: Aleskandarany, Mohammed A.¹, Sonbul, Sultan N.¹, Mukherjee, Abhik¹, Rakha, Emad A.¹ Emad.Rakha@nottingham.ac.uk

Publikováno v: Pathobiology. Sep2015, Vol. 82 Issue 3/4, p113-123. 11p.

Further evidence to support bimodality of oestrogen receptor expression in breast cancer

Autor: Muftah, Abir A., Aleskandarany, Mohammed, Sonbul, Sultan N., Nolan, Christopher C., Diez Rodriguez, Maria, Caldas, Carlos, Ellis, Ian O., Green, Andrew R., Rakha, Emad A.

Aims: Although oestrogen receptor (ER)‐negative breast cancers (BCs) do not respond to hormone therapy, the response of ER‐positive BCs is reported to be variable, which may suggest a dose‐dependent effect. The aim of this study was to assess t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::ca3f23965a29d279b843f72f12b16d2b

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Chemokine (C-C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma.

Autor: Sonbul SN; Division of Cancer and Stem Cells, School of MedicineThe University of Nottingham, and Nottingham City Hospital, Nottingham University Hospitals NHS TrustNottinghamUK.; Biochemistry Department, Faculty of SciencesKing Abdulaziz UniversityJeddahKingdom of Saudi Arabia., Gorringe KL; Cancer Genomics Program, Peter MacCallum Cancer Centre, Melbourne, and The Sir Peter MacCallum Department of OncologyUniversity of MelbourneParkvilleAustralia., Aleskandarany MA; Division of Cancer and Stem Cells, School of MedicineThe University of Nottingham, and Nottingham City Hospital, Nottingham University Hospitals NHS TrustNottinghamUK., Mukherjee A; Division of Cancer and Stem Cells, School of MedicineThe University of Nottingham, and Nottingham City Hospital, Nottingham University Hospitals NHS TrustNottinghamUK., Green AR; Division of Cancer and Stem Cells, School of MedicineThe University of Nottingham, and Nottingham City Hospital, Nottingham University Hospitals NHS TrustNottinghamUK., Ellis IO; Division of Cancer and Stem Cells, School of MedicineThe University of Nottingham, and Nottingham City Hospital, Nottingham University Hospitals NHS TrustNottinghamUK., Rakha EA; Division of Cancer and Stem Cells, School of MedicineThe University of Nottingham, and Nottingham City Hospital, Nottingham University Hospitals NHS TrustNottinghamUK.

Publikováno v: The journal of pathology. Clinical research [J Pathol Clin Res] 2017 Mar 30; Vol. 3 (2), pp. 105-114. Date of Electronic Publication: 2017 Mar 30 (Print Publication: 2017).